bf/NASDAQ:KTTA_icon.jpeg

NASDAQ:KTTA

Pasithea Therapeutics Corp.

  • Stock

USD

Last Close

4.56

26/07 20:00

Market Cap

5.45M

Beta: -

Volume Today

2.75K

Avg: 58.36K

PE Ratio

−0.56

PFCF: −0.43

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.00
-
0.01
3,712.42%
cash conversion cycle
226.65
-
cash per share
5.09
-
1.31
74.21%
13.31
914.28%
company equity multiplier
1.03
-
1.04
0.93%
1.06
2.52%
1.12
4.99%
days of inventory outstanding
days of payables outstanding
days of sales outstanding
226.65
-
dividend yield
ebit per revenue
-299.26
-
-30.45
89.82%
ebt per ebit
0.48
-
0.94
95.06%
0.97
3.18%
effective tax rate
-0.00
-
0.06
27,115.70%
-29.27
46,455.89%
enterprise value multiple
7.67
-
1.09
85.84%
0.47
56.92%
fixed asset turnover
0.75
-
0.39
48.13%
free cash flow per share
-0.31
-
-0.66
115.34%
-10.97
1,559.18%
gross profit margin
-0.15
-
0.77
622.27%
interest coverage
-8.87K
-
-145.26K
1,537.11%
inventory turnover
long term debt to capitalization
0.02
-
net income per ebt
1.00
-
0.94
6.34%
1.03
9.86%
net profit margin
-144.34
-
-26.83
81.41%
operating cash flow per share
-0.31
-
-0.58
89.03%
-10.95
1,798.01%
operating cycle
226.65
-
operating profit margin
-299.26
-
-30.45
89.82%
payables turnover
pretax profit margin
-144.30
-
-28.64
80.15%
price fair value
0.36
-
0.38
6.51%
0.39
1.69%
receivables turnover
1.61
-
return on assets
-0.04
-
-0.29
608.78%
-0.61
111.48%
return on capital employed
-0.09
-
-0.34
301.36%
-0.68
98.88%
return on equity
-0.04
-
-0.31
626.65%
-0.68
122.04%
total debt to capitalization
0.02
-
0.00
83.70%

All numbers in USD (except ratios and percentages)